Is TVTX a good stock to buy? We came across a bullish thesis on Travere Therapeutics, Inc. on Biotech Distilled’s Substack.

Over the last 7 days, the United States market has dropped 2.5%, yet it has risen by 23% over the past year, with earnings expected to grow by 17% annually in the coming years. In this environment, ...

Wells Fargo analyst Mohit Bansal maintained a Buy rating on Travere Therapeutics yesterday and set a price target of $65.00. Designed for personal research, portfolio monitoring, and AI-assisted ...

EVEREST MED (01952.HK) announced that its wholly owned subsidiary, Everest Medicines (Singapore) Pte. Ltd., as licensor, has ...

As part of the campaign, AKF has enhanced its webpage on FSGS with expanded information on diagnosis, treatment options and types of FSGS. AKF also created accompanying digital guides for patients on ...

Detailed price information for Acumen Pharmaceuticals Inc (ABOS-Q) from The Globe and Mail including charting and trades.

Healthcare companies balance science, innovation and hope in the pursuit of better diagnostics, treatments and even cures, ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Timothy Coughlin to its Board of Directors and as Chair of the Audit Committee, effective June 9, 2026.

Stock Market Today: The Dow Jones index rises Friday on U.S.-Iran peace deal hopes. SpaceX stock jumps on its debut.

In its largest acquisition to date, Incyte Inc. snagged rights to phase III-stage VGA-039, a monoclonal antibody the firm said could offer a new standard of care in von Willebrand disease (VWD), in a ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...